Examining the Effects of Morning and Evening Exercise on Glucose Regulation in Adults With Prediabetes
Key facts
- Who runs it
- University of Colorado, Denver
- Where
- Aurora, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Started
- 1 Feb 2024
- Ended
- Jun 2026
- Type of study
- Interventional, 2 groups
- Treatments tested
- AM Exercise
- PM Exercise
- Record updated
- 24 December 2025
- Why it stopped
- Study PI Moved Institutions
Who can take part
- Age
- 20 years to 40 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 18 criteriaShow less
Who can take part
- Age 20-40 years
- Biologically female participants with regular menstruation
- Body mass index (BMI) ≥ 30.0 to ≤ 40.0 kg/m2
- Prediabetes as defined by the American Diabetes Association (HgbA1c ≥ 5.7% to < 6.5% or fasting glucose ≥ 100 to < 126 mg/dL)
- Physically inactive (< 100 min/wk of regular exercise)
- No contraindications to exercise or limitations on ability to be physically active
- Weight stable (weight change < 5kg in past 3 months)
- Not currently pregnant or lactating, not pregnant within the past 6 months or planning to become pregnant in the next 6 months
Who cannot take part
- Current use of medications that effect SI (oral steroids, metformin, GLP1 receptor agonists, etc)
- History or symptoms suggestive of cardiovascular disease or congestive heart failure
- Diastolic blood pressure > 100 mmHg, systolic blood pressure > 160 mmHg, or resting heart rate > 100 bpm
- Chronic kidney disease (CKD, stage 4 or higher)
- Clinically significant abnormality on resting ECG, presence, or history of any other metabolic or chronic health problems which would affect appetite, food intake, energy metabolism, or ability to participate in exercise,
- History of obstructive sleep apnea, primary insomnia, night-time shiftwork, rotating work, or other atypical sleep patterns
- History of type 1 or type 2 DM (or fasting glucose ≥126 mg/dL or Hemoglobin A1C ≥6.5% on screening labs)
- TSH, electrolytes, hematocrit, white blood cell count, or platelets significantly outside the normal reference range on screening labs
- Triglycerides > 400 or LDL > 200 on screening labs
- Current or recent (within 1 month) zero or very low carbohydrate diet (< 10% daily calories from carbohydrates)
Where in United States
- University of ColoradoAurora, United States
About the trial
What the trial wants to find out
Purpose of the Study: This study is to learn more about how exercising at different times of the day (morning versus evening) affects metabolism of glucose in the body, sleep, activity outside of exercise, and other factors.
Read full original descriptionShow less
Procedures:
* 2 screening visits to make sure you are eligible to be in the study. This will include a fasting blood draw and heart tracing (EKG). * If you are eligible, you will complete both exercise conditions in a random order. All participants in the study will complete the following separated by 3-4 weeks:
* Baseline condition of NO exercise * Morning exercise for 3 days in a row * Evening exercise for 3 days in a row * You will be provided with an example diet to follow for the days you are completing the baseline and exercise conditions (three days total for each condition). This diet will be a "traditional" diet with a controlled amount of carbohydrates, protein, and fat per day. The investigators will provide you with examples of meals to eat during this time. * You will be asked questions and complete questionnaires about your health history, sleeping and awakening habits, and sleepiness levels. * You will undergo one x-ray scan to measure your level of body fat. * You will be asked to wear an activity monitor and sleep monitor for 6 days in a row three times during this study. * You will be asked to wear a continuous glucose monitor (CGM) for 6 days in a row three times during this study. * You will be asked to measure your saliva melatonin levels three times in the study. This will be done once per hour for 5 hours (a total of 6 saliva samples). * You will be asked to complete a procedure called a "hyperinsulinemic-euglycemic clamp" where you will have an IV placed and insulin and glucose infused with frequent lab and finger stick blood sugars monitored closely. This will be done 3 times during the study.
The 2 groups in the trial
- Crossover - AM firstTreatment being tested
Crossover design with AM exercise first
Treatment: AM Exercise and PM Exercise
- Crossover - PM firstTreatment being tested
Crossover design with PM exercise first
Treatment: AM Exercise and PM Exercise
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 24 December 2025